NCT00985998 - Nimotuzumab in Combination With Cisplatin and Docetaxel for Patients With Advanced Non-small Cell Lung Cancer | Biotech Hunter

Timeline

Start Date

September 30, 2009

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

Nimotuzumab and chemotherapy

"The chemotherapy treament：docetaxel( 75mg/m2/d,every21days,for4\~6cycles) and cisplatin(total dose 75mg/m2 on day 2,3,4,every21days,for4\~6cycles).~the nimotuzumab treatment:3 levels (200mg/w,400mg/w,600mg/w,weekly,for12\~18 weeks)."

Trial Locations (1)

100000

Cancer Institute & Hospital, Chinese Academy of Medical Sciences, Beijing